142 related articles for article (PubMed ID: 37751121)
1. Attitude of BRCA1/2 mutation carriers towards fertility preservation, family planning and preimplantation genetic testing for primary prevention of breast and ovarian cancer in the next generation.
Nahshon C; Lavie O; Oron G
J Assist Reprod Genet; 2023 Dec; 40(12):2835-2842. PubMed ID: 37751121
[TBL] [Abstract][Full Text] [Related]
2. Preimplantation genetic testing for monogenic disorders: clinical experience with BRCA1 and BRCA2 from 2010-2021.
Barrett F; Shaw J; Besser AG; Grifo JA; Blakemore JK
J Assist Reprod Genet; 2023 Nov; 40(11):2705-2713. PubMed ID: 37691027
[TBL] [Abstract][Full Text] [Related]
3. BRCA mutation carriers show normal ovarian response in in vitro fertilization cycles.
Shapira M; Raanani H; Feldman B; Srebnik N; Dereck-Haim S; Manela D; Brenghausen M; Geva-Lerner L; Friedman E; Levi-Lahad E; Goldberg D; Perri T; Eldar-Geva T; Meirow D
Fertil Steril; 2015 Nov; 104(5):1162-7. PubMed ID: 26335130
[TBL] [Abstract][Full Text] [Related]
4. Cost effectiveness of in vitro fertilisation and preimplantation genetic testing to prevent transmission of BRCA1/2 mutations.
Lipton JH; Zargar M; Warner E; Greenblatt EE; Lee E; Chan KKW; Wong WWL
Hum Reprod; 2020 Feb; 35(2):434-445. PubMed ID: 32099994
[TBL] [Abstract][Full Text] [Related]
5. Knowledge, acceptability and personal attitude toward pre-implantation 1 genetic testing (PGT) and pre-natal diagnosis (PND) for females carrying BRCA pathogenic variant according to fertility preservation experience.
Dervin T; Ranisavjevic N; Laot L; Mayeur A; Duperier C; Steffann J; Borghese R; Stoppa-Lyonnet D; Frydman N; Benachi A; Sonigo C; Grynberg M
J Assist Reprod Genet; 2023 Jun; 40(6):1381-1390. PubMed ID: 37154838
[TBL] [Abstract][Full Text] [Related]
6. Preimplantation genetic testing for carriers of BRCA1/2 pathogenic variants.
Vuković P; Peccatori FA; Massarotti C; Miralles MS; Beketić-Orešković L; Lambertini M
Crit Rev Oncol Hematol; 2021 Jan; 157():103201. PubMed ID: 33333149
[TBL] [Abstract][Full Text] [Related]
7. Fertility preservation and preimplantation genetic assessment for women with breast cancer.
Sciorio R; Anderson RA
Cryobiology; 2020 Feb; 92():1-8. PubMed ID: 31863734
[TBL] [Abstract][Full Text] [Related]
8. BRCA1/2 gene mutations do not affect the capacity of oocytes from breast cancer candidates for fertility preservation to mature in vitro.
Grynberg M; Dagher Hayeck B; Papanikolaou EG; Sifer C; Sermondade N; Sonigo C
Hum Reprod; 2019 Feb; 34(2):374-379. PubMed ID: 30561604
[TBL] [Abstract][Full Text] [Related]
9. Fertility preservation in BRCA-mutated women: when and how?
Grynberg M; Raad J; Comtet M; Vinolas C; Cédrin-Durnerin I; Sonigo C
Future Oncol; 2018 Feb; 14(5):483-490. PubMed ID: 29327596
[TBL] [Abstract][Full Text] [Related]
10. Fertility preservation in BRCA mutation carriers.
Revelli A; Salvagno F; Delle Piane L; Casano S; Evangelista F; Pittatore G; Razzano A; Marchino GL; Gennarelli G; Benedetto C
Minerva Ginecol; 2016 Oct; 68(5):587-601. PubMed ID: 26997146
[TBL] [Abstract][Full Text] [Related]
11. Fertility preservation in women harboring deleterious BRCA mutations: ready for prime time?
Peccatori FA; Mangili G; Bergamini A; Filippi F; Martinelli F; Ferrari F; Noli S; Rabaiotti E; Candiani M; Somigliana E
Hum Reprod; 2018 Feb; 33(2):181-187. PubMed ID: 29207007
[TBL] [Abstract][Full Text] [Related]
12. Hereditary breast and ovarian cancer and reproduction: an observational study on the suitability of preimplantation genetic diagnosis for both asymptomatic carriers and breast cancer survivors.
Derks-Smeets IA; de Die-Smulders CE; Mackens S; van Golde R; Paulussen AD; Dreesen J; Tournaye H; Verdyck P; Tjan-Heijnen VC; Meijer-Hoogeveen M; De Greve J; Geraedts J; De Rycke M; Bonduelle M; Verpoest WM
Breast Cancer Res Treat; 2014 Jun; 145(3):673-81. PubMed ID: 24748567
[TBL] [Abstract][Full Text] [Related]
13. Impact of BRCA1 and BRCA2 mutations on ovarian reserve and fertility preservation outcomes in young women with breast cancer.
Porcu E; Cillo GM; Cipriani L; Sacilotto F; Notarangelo L; Damiano G; Dirodi M; Roncarati I
J Assist Reprod Genet; 2020 Mar; 37(3):709-715. PubMed ID: 31872386
[TBL] [Abstract][Full Text] [Related]
14. Decision-making on preimplantation genetic diagnosis and prenatal diagnosis: a challenge for couples with hereditary breast and ovarian cancer.
Derks-Smeets IA; Gietel-Habets JJ; Tibben A; Tjan-Heijnen VC; Meijer-Hoogeveen M; Geraedts JP; van Golde R; Gomez-Garcia E; van den Bogaart E; van Hooijdonk M; de Die-Smulders CE; van Osch LA
Hum Reprod; 2014 May; 29(5):1103-12. PubMed ID: 24603131
[TBL] [Abstract][Full Text] [Related]
15. BRCA1 mutation carriers have a lower number of mature oocytes after ovarian stimulation for IVF/PGD.
Derks-Smeets IAP; van Tilborg TC; van Montfoort A; Smits L; Torrance HL; Meijer-Hoogeveen M; Broekmans F; Dreesen JCFM; Paulussen ADC; Tjan-Heijnen VCG; Homminga I; van den Berg MMJ; Ausems MGEM; de Rycke M; de Die-Smulders CEM; Verpoest W; van Golde R
J Assist Reprod Genet; 2017 Nov; 34(11):1475-1482. PubMed ID: 28831696
[TBL] [Abstract][Full Text] [Related]
16. BRCA carriers have similar reproductive potential at baseline to noncarriers: comparisons in cancer and cancer-free cohorts undergoing fertility preservation.
Gunnala V; Fields J; Irani M; D'Angelo D; Xu K; Schattman G; Rosenwaks Z
Fertil Steril; 2019 Feb; 111(2):363-371. PubMed ID: 30527950
[TBL] [Abstract][Full Text] [Related]
17. Fertility treatments and invasive epithelial ovarian cancer risk in Jewish Israeli BRCA1 or BRCA2 mutation carriers.
Perri T; Lifshitz D; Sadetzki S; Oberman B; Meirow D; Ben-Baruch G; Friedman E; Korach J
Fertil Steril; 2015 May; 103(5):1305-12. PubMed ID: 25792249
[TBL] [Abstract][Full Text] [Related]
18. Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study.
Uyei A; Peterson SK; Erlichman J; Broglio K; Yekell S; Schmeler K; Lu K; Meric-Bernstam F; Amos C; Strong L; Arun B
Cancer; 2006 Dec; 107(12):2745-51. PubMed ID: 17109443
[TBL] [Abstract][Full Text] [Related]
19. BRCA mutations and reproduction.
Daum H; Peretz T; Laufer N
Fertil Steril; 2018 Jan; 109(1):33-38. PubMed ID: 29307397
[TBL] [Abstract][Full Text] [Related]
20. PGD for hereditary breast and ovarian cancer: the route to universal tests for BRCA1 and BRCA2 mutation carriers.
Drüsedau M; Dreesen JC; Derks-Smeets I; Coonen E; van Golde R; van Echten-Arends J; Kastrop PM; Blok MJ; Gómez-García E; Geraedts JP; Smeets HJ; de Die-Smulders CE; Paulussen AD
Eur J Hum Genet; 2013 Dec; 21(12):1361-8. PubMed ID: 23531862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
